ELIXIR PHARM
Business purpose.
exercice de la profession de pharmacien d'officine
Identity
- Legal form
- Regulated profession company as an SAS (SELAS)
- Activity
- Dispensing chemist in specialised stores (47.73Z)
- Sector
- Retail trade, except of motor vehicles and motorcycles
- Headcount
- 6 to 9 employees
- Created
- 4 Aug 2020
- Share capital
- 5,000.00 EUR
- Registered with the trade register
- 8 Sep 2020
- Financial year end
- 31/12
- Establishments
- 1
Directors
- Stéphane-Alexandre ROSENHEK 49 years old, 10/1977 Président de la SELAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- SCI 2R2G via Stéphane-Alexandre ROSENHEK
- SCI KAMASAR via Stéphane-Alexandre ROSENHEK
Establishments
Financial strength
Financial score
62 / 100 C
Confidence: low · computed on the financial year ended 31 Dec 2022
- Equity to assets (41.6 %)
- 15.7 out of 30
- EBITDA margin (19.4 %)
- 19.0 out of 25
- Liquidity (356.8 %)
- 13.2 out of 20
- Debt (83.5 %)
- 7.7 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
73 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (6.3 years)
- 12.5 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2022 | 1,392,675 € | — | 270,013 € | 212,922 € |
| 31 Dec 2021 | 0 € | first year on record | 0 € | 209,612 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la pharmacie d'officine du 3 décembre 1997. Etendue par arrêté du 13 août 1998 (JO du 8 septembre 1998).
IDCC 1996 · in force, extended · 1 establishment · declared in July 2026
Legal notices
-
Filing of accounts 7 Sep 2022
- Court :
- Greffe du Tribunal d'Instance de colmar
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220173, annonce n 2885 · Proof of publication (PDF)
-
Sale or transfer 2 Feb 2021
- Court :
- GREFFE DU TRIBUNAL D'INSTANCE DE COLMAR
- Filing :
- Acte sous seing privé en date à STRASBOURG du 10 septembre 2020, enregistré au Service Départemental de l'Enregistrement de MULHOUSE, le 02 octobre 20220 sous dossier 2020 00028915, référence 6804P61 2020 A003326 Adresse du vendeur : Pharmacie des Colmariens 20 Grand'rue 68000 COLMAR Parutions : L'Ami du Peuple Hebdo 1ère insertion le 25/10/20 + insertion rectificative le 07/02/2021 Adresse de l'ancien propriétaire : 20 Grand rue 68000 Colmar
BODACC A n 20210022, annonce n 1746 · Proof of publication (PDF)
-
Incorporation 10 Nov 2020
- Court :
- GREFFE DU TRIBUNAL D'INSTANCE DE COLMAR
BODACC A n 20200219, annonce n 1641 · Proof of publication (PDF)
Filings and accounts
- Formality 20 Jan 2026
Change history
- officer_appointed (empty) → Président de la SELAS 9 Oct 2026
- capital (empty) → 5000.00 3 Oct 2026
Frequently asked questions about ELIXIR PHARM
- What is the SIREN number of ELIXIR PHARM?
- The SIREN number of ELIXIR PHARM is 888206505. Its intra-community VAT number is FR39888206505.
- Where is the head office of ELIXIR PHARM?
- Head office address: 20 GRAND'RUE, 68000 COLMAR.
- When was ELIXIR PHARM founded?
- ELIXIR PHARM was founded on 4 Aug 2020.
- What does ELIXIR PHARM do?
- Its declared main activity is: Dispensing chemist in specialised stores (NAF code 47.73Z).
- Who runs ELIXIR PHARM?
- The officer listed in the register is Stéphane-Alexandre ROSENHEK (Président de la SELAS).
- What is the revenue of ELIXIR PHARM?
- The latest published revenue is 1,392,675 €, for the 2022 financial year.
- How many employees does ELIXIR PHARM have?
- The declared headcount is 6 to 9 employees. Insee data for 2024.
- Is ELIXIR PHARM subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.